Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface
- 1 August 2002
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 124 (2) , 321-332
- https://doi.org/10.1067/mtc.2002.122551
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- High Molecular Weight Kininogen Deficiency: a Patient who Underwent Cardiac SurgeryThrombosis and Haemostasis, 2001
- Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinizationThe Annals of Thoracic Surgery, 1999
- Two-Chain Factor VIIa Generated in the Pericardium During Surgery With Cardiopulmonary BypassArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Systemic Inflammation Present in Patients Undergoing CABG Without Extracorporeal CirculationChest, 1998
- Activation of Coagulation and Fibrinolysis During Cardiothoracic OperationsPublished by Elsevier ,1998
- Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Pericardial Blood Activates the Extrinsic Coagulation Pathway During Clinical Cardiopulmonary BypassCirculation, 1996
- High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytesThe Annals of Thoracic Surgery, 1995
- Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypassThe Lancet, 1994
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983